Literature DB >> 10648803

The CREC family, a novel family of multiple EF-hand, low-affinity Ca(2+)-binding proteins localised to the secretory pathway of mammalian cells.

B Honoré1, H Vorum.   

Abstract

The CREC family consists of a number of recently discovered multiple (up to seven) EF-hand proteins that localise to the secretory pathway of mammalian cells. At present, the family includes reticulocalbin, ERC-55/TCBP-49/E6BP, Cab45, calumenin and crocalbin/CBP-50. Similar proteins are found in quite diverse invertebrate organisms such as DCB-45 and SCF in Drosophila melanogaster, SCF in Bombyx mori, CCB-39 in Caenorhabditis elegans and Pfs40/PfERC in Plasmodium falciparum. The Ca(2+) affinity is rather low with dissociation constants around 10(-4)-10(-3) M. The proteins may participate in Ca(2+)-regulated activities. Recent evidence has been obtained that some CREC family members are involved in pathological activities such as malignant cell transformation, mediation of the toxic effects of snake venom toxins and putative participation in amyloid formation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10648803     DOI: 10.1016/s0014-5793(99)01780-9

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  51 in total

1.  Proteomic analysis identification of a pattern of shared alterations in the secretome of dermal fibroblasts from systemic sclerosis and nephrogenic systemic fibrosis.

Authors:  Francesco Del Galdo; M Alexander Shaw; Sergio A Jimenez
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

2.  Lumenal protein sorting to the constitutive secretory pathway of a regulated secretory cell.

Authors:  Roberto Lara-Lemus; Ming Liu; Mark D Turner; Philipp Scherer; Gudrun Stenbeck; Puneeth Iyengar; Peter Arvan
Journal:  J Cell Sci       Date:  2006-04-11       Impact factor: 5.285

3.  siRNA silencing of calumenin enhances functional factor IX production.

Authors:  Nadeem Wajih; Susan M Hutson; Reidar Wallin
Journal:  Blood       Date:  2006-08-10       Impact factor: 22.113

4.  Differential liver protein expression during schistosomiasis.

Authors:  Marina Harvie; Thomas William Jordan; Anne Camille La Flamme
Journal:  Infect Immun       Date:  2006-11-13       Impact factor: 3.441

5.  A proteomic approach reveals transient association of reticulocalbin-3, a novel member of the CREC family, with the precursor of subtilisin-like proprotein convertase, PACE4.

Authors:  Akihiko Tsuji; Yayoi Kikuchi; Yukimi Sato; Shizuyo Koide; Keizo Yuasa; Masami Nagahama; Yoshiko Matsuda
Journal:  Biochem J       Date:  2006-05-15       Impact factor: 3.857

6.  A cytosolic splice variant of Cab45 interacts with Munc18b and impacts on amylase secretion by pancreatic acini.

Authors:  Patrick P L Lam; Kati Hyvärinen; Maria Kauppi; Laura Cosen-Binker; Saara Laitinen; Sirkka Keränen; Herbert Y Gaisano; Vesa M Olkkonen
Journal:  Mol Biol Cell       Date:  2007-04-18       Impact factor: 4.138

7.  Enhanced functional recombinant factor VII production by HEK 293 cells stably transfected with VKORC1 where the gamma-carboxylase inhibitor calumenin is stably suppressed by shRNA transfection.

Authors:  Nadeem Wajih; John Owen; Reidar Wallin
Journal:  Thromb Res       Date:  2008-01-03       Impact factor: 3.944

8.  Reticulocalbin 2 correlates with recurrence and prognosis in colorectal cancer.

Authors:  Gang Wang; Qian Wang; Yongguo Fan; Xianli He
Journal:  Am J Cancer Res       Date:  2017-11-01       Impact factor: 6.166

Review 9.  PMR1/SPCA Ca2+ pumps and the role of the Golgi apparatus as a Ca2+ store.

Authors:  Frank Wuytack; Luc Raeymaekers; Ludwig Missiaen
Journal:  Pflugers Arch       Date:  2003-02-15       Impact factor: 3.657

10.  Proteomic Analysis Revealed the Important Role of Vimentin in Human Cervical Carcinoma HeLa Cells Treated With Gambogic Acid.

Authors:  Qingxi Yue; Lixing Feng; Biyin Cao; Miao Liu; Dongmei Zhang; Wanying Wu; Baohong Jiang; Min Yang; Xuan Liu; Dean Guo
Journal:  Mol Cell Proteomics       Date:  2015-10-23       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.